Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
about
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidateThe atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminusHuman bocavirus capsid structure: insights into the structural repertoire of the parvoviridaeCross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroupsAdeno-associated virus for cystic fibrosis gene therapyStructure of Adeno-Associated Virus Serotype 8, a Gene Therapy VectorStructural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal TraffickingStructure–function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6)Structural Insights into Adeno-Associated Virus Serotype 5Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV EvolutionProof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platformStructure of neurotropic adeno-associated virus AAVrh.8.The structure of human parvovirus B19Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer.Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking.A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery.PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivoMutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.Comparative analysis of adeno-associated virus capsid stability and dynamicsOvercoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectorsThe potential of gene transfer into primary B-CLL cells using recombinant virus vectors.Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism.Neuronal affinity of a C7C loop peptide identified through phage display.Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transferIn vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.Molecular engineering of viral gene delivery vehiclesDNA shuffling of adeno-associated virus yields functionally diverse viral progenyDirected evolution of adeno-associated virus for glioma cell transductionSites in the AAV5 capsid tolerant to deletions and tandem duplications.Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library.The role of nuclear localization signal in parvovirus life cycle.The 2.8 Å Electron Microscopy Structure of Adeno-Associated Virus-DJ Bound by a Heparinoid Pentasaccharide.AAV's anatomy: roadmap for optimizing vectors for translational successCystic fibrosis: exploiting its genetic basis in the hunt for new therapiesTunable protease-activatable virus nanonodesA NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION.DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids
P2860
Q24288709-15428CDB-01BC-4F3B-B3BD-69EE94FA184DQ24533492-8C6265AF-7E7A-459F-9C46-97E543A9D5D0Q24563214-A302A2F9-D3F8-4F02-8649-73AD3BDCE9F6Q24606666-E928D132-00BB-4561-9B63-005FBB5AF609Q24623923-5832F153-40B9-4A07-92A9-EB43E84B1474Q26823156-A36106F0-1266-481A-A227-BEF1EAECFB9EQ27647639-D2254488-F8C5-4B9A-85FE-169DEDA150C9Q27664641-83EF01BE-E478-44AE-B2B2-3E5203BAFAC0Q27673394-FA899A30-26A9-46BF-A693-CE6B013590BAQ27673885-D5706B75-31ED-4564-AECC-AC6CE69D3FC1Q27679454-591349DD-24F1-4B85-AD14-56F736BED902Q27681034-48EB937B-5DB2-431B-ADCF-F31060FB9389Q28083324-423C655F-15B9-475C-B248-A498F61350ABQ28596492-DCC962EB-E95B-4E6F-81C3-D350FAB4E920Q30152836-DB98C705-282F-4AFD-96BA-FA1C12FFFA4EQ30163895-5F07CF7D-9A42-482A-9D9B-326291E78B98Q30419813-95832AF4-D4D4-4984-82DF-19E8E823007FQ30476153-C032F786-A054-4D51-AF27-78CED3E5DE6DQ30483589-6CD14D26-5D2A-4F08-9F50-1C9B19800C59Q30493965-128C109D-2348-42DE-A97E-E1C884AE17E2Q30495947-8835960A-4793-44A2-B85E-77F2A8842388Q30557598-ADEB4861-6992-4602-A958-4DCB38E5804AQ30650955-FCE81983-FEC3-4B49-8446-B48977D34A46Q31104353-9FC7A9AA-4AB5-4B3E-BCB5-D8E0BFF0B7A4Q33248410-FDC4BA16-57D6-405E-8818-F0BF32F93902Q33252514-110B3F05-618B-413A-B0E9-DE943898AE77Q33296224-49D23AC5-15E7-47A3-80C2-222043E82CCDQ33327474-29FF951B-7D1D-45BE-86F2-D9ABDD277561Q33353795-164FC760-93BA-4209-A0CF-A035327D4CEDQ33363531-6D12A3A8-C3B0-4993-A487-540DB29B2AE1Q33484220-43CCAC8C-70BD-486C-8A09-099ACA631D19Q33526697-AF032CA3-183E-4477-939B-5AF2C4FC5C50Q33555864-5E332DCD-AD7D-4427-8AC8-367E815263CBQ33564577-6676E617-F38E-4FA7-82A2-9F6D985B91C6Q33633258-B9854661-0326-40C2-9948-EEDA545CB623Q33659389-6B01D5AF-5BE7-4937-88A6-0007F12A0AFCQ33664918-FBD3F4FD-3BE0-4822-87D3-B770AFAB4978Q33716080-C6F16C85-20E1-4F41-9867-D937169BBFF8Q33908400-6685C0C3-A33D-4F97-A9A9-24AEA23BB6BAQ33951407-05BE7FF9-38A9-4D4A-869B-CC3058DD75DF
P2860
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Mutational analysis of the ade ...... 2 vectors with altered tropism
@nl
Mutational analysis of the ade ...... vectors with altered tropism.
@ast
Mutational analysis of the ade ...... vectors with altered tropism.
@en
Mutational analysis of the ade ...... vectors with altered tropism.
@en-gb
type
label
Mutational analysis of the ade ...... 2 vectors with altered tropism
@nl
Mutational analysis of the ade ...... vectors with altered tropism.
@ast
Mutational analysis of the ade ...... vectors with altered tropism.
@en
Mutational analysis of the ade ...... vectors with altered tropism.
@en-gb
prefLabel
Mutational analysis of the ade ...... 2 vectors with altered tropism
@nl
Mutational analysis of the ade ...... vectors with altered tropism.
@ast
Mutational analysis of the ade ...... vectors with altered tropism.
@en
Mutational analysis of the ade ...... vectors with altered tropism.
@en-gb
P2093
P2860
P3181
P1433
P1476
Mutational analysis of the ade ...... vectors with altered tropism.
@en
P2093
M Agbandje-McKenna
N Muzyczka
P2860
P304
P3181
P356
10.1128/JVI.74.18.8635-8647.2000
P407
P577
2000-09-01T00:00:00Z